Intercept Pharmaceuticals (ICPT): Dew- Gilead CEO expresses interest in NA...

SMALL CAP PRO

Realtime Streaming Prices and Level 2.

START YOUR FREE TRIAL >

Stock Options

NEW to INVESTORSHUB

Intercept Pharmaceuticals (ICPT)

Reply Private New

Replies (1) Next 10 Prev Next

Send PM

Followers	221
Posts	28015
Boards Moderated	0
Alias Born	01/12/2013

FREE
ICPT REPORT

Re: DewDiligence post# 575

Tuesday, 01/21/2020 11:23:28 PM

Tuesday, January 21, 2020 11:23:28 PM

Dew- Gilead CEO expresses interest in NASH and cancer assets, Dealreporter says When pressed by an analyst during its Q3 earnings call, Gilead Sciences' (GILD) CEO Daniel O'Day said the company is looking carefully in the areas of nonalcoholic steatohepatitis and in oncology, said Dealreporter, according to contacts. If Gilead "is serious about wading into NASH, which would build on its liver franchise-building expertise in HCV, Intercept Pharmaceuticals (ICPT) could be a name to watch," the deal-focused publication stated, according to contacts.

Read more at:
https://thefly.com/landingPageNews.php?id=2981475

Also:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=137563501

My point, both AMRN & ICPT are key to GILD NASH success.

BB

If you're not good at being yourself, then maybe that's being yourself!

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent ICPT News

Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 03/16/2023 08:08:17 PM
Intercept Says FDA Sets AdCom Meeting on Obeticholic Acid • Dow Jones News • 03/10/2023 03:05:00 PM
Intercept Announces FDA Advisory Committee Meeting Date for Obeticholic Acid as a Treatment for Pre-Cirrhotic Liver Fibrosis due to NASH • GlobeNewswire Inc. • 03/10/2023 02:05:00 PM
Intercept Pharmaceuticals to Conduct One-on-One Meetings with Investors at the Barclays Global Healthcare Conference March 14, 2023 • GlobeNewswire Inc. • 03/09/2023 01:00:00 PM
Annual Report (10-k) • Edgar (US Regulatory) • 03/02/2023 09:33:43 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 03/02/2023 12:06:06 PM
Intercept Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates; Issues 2023 Financial Guidance • GlobeNewswire Inc. • 03/02/2023 12:00:00 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 02/27/2023 01:01:09 PM
Intercept Pharmaceuticals to Participate in Cowen’s 43rd Annual Health Care Conference on March 7, 2023 • GlobeNewswire Inc. • 02/27/2023 01:00:00 PM
Intercept to Announce Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023 • GlobeNewswire Inc. • 02/23/2023 01:00:00 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 02/21/2023 01:01:29 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/16/2023 09:03:54 PM
Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/14/2023 09:03:34 PM
Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/09/2023 04:49:43 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/03/2023 09:02:33 PM
Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/02/2023 05:26:01 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/31/2023 09:05:33 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/31/2023 09:05:13 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/31/2023 09:04:43 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/31/2023 09:04:15 PM
Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 01/31/2023 06:59:42 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 01/25/2023 01:01:38 PM
FDA Accepts Intercept’s New Drug Application for OCA for the Treatment of Pre-Cirrhotic Liver Fibrosis Due to NASH • GlobeNewswire Inc. • 01/19/2023 01:00:00 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 01/17/2023 01:01:39 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 01/11/2023 01:01:54 PM

More ICPT News

InvestorsHub NewsWire

Hollywall Entertainment, Inc. (HWAL) forms new Technology Division • HWAL • Mar 20, 2023 12:50 PM

Thunder Energies Retains Global IR Firm • TNRG • Mar 20, 2023 9:30 AM

Tudor Gold Announces Significant Upgrade to Mineral Resource Estimate for the Goldstorm Porphyry Deposit..... • TUD • Mar 16, 2023 11:56 AM

Golden Matrix Reports First Quarter Financial Results With Record Revenues of $10.78 Million • GMGI • Mar 16, 2023 9:24 AM

Swifty Global Releases Details of Its Annual Shareholder Meeting • DRCR • Mar 16, 2023 9:18 AM

Authentic Holdings, Inc., to Acquire Maybacks Global Entertainment LLC • AHRO • Mar 16, 2023 8:00 AM

Start posting your company's news

Only $200 per official company press release!